Pathogenic variants in CACNA1A have been implicated in a wide spectrum of neurological phenotypes, including episodic ataxia type 2, familial hemiplegic migraine, epileptic encephalopathy, and autism spectrum disorder [14,29,30]. This evidence concerns the gene CACNA1A and episodic ataxia type 2.